| Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children KM Walsh, AP Chokkalingam, LI Hsu, C Metayer, AJ De Smith, DI Jacobs, ... Leukemia 27 (12), 2416-2419, 2013 | 65 | 2013 |
| PDE11A associations with asthma: results of a genome-wide association scan AT DeWan, EW Triche, X Xu, LI Hsu, C Zhao, K Belanger, K Hellenbrand, ... Journal of allergy and clinical immunology 126 (4), 871-873. e9, 2010 | 60 | 2010 |
| Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics AP Chokkalingam, LI Hsu, C Metayer, HM Hansen, SR Month, ... Cancer Causes & Control 24, 1789-1795, 2013 | 54 | 2013 |
| Attempted replication of 50 reported asthma risk genes identifies a SNP in RAD50 as associated with childhood atopic asthma W Murk, K Walsh, LI Hsu, L Zhao, MB Bracken, AT DeWan Human Heredity 71 (2), 97-105, 2011 | 51 | 2011 |
| Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype KM Walsh, AJ de Smith, AP Chokkalingam, C Metayer, GV Dahl, L Hsu, ... Blood, The Journal of the American Society of Hematology 121 (23), 4808-4809, 2013 | 50 | 2013 |
| A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum KM Walsh, M Choi, K Oberg, MH Kulke, JC Yao, C Wu, M Jurkiewicz, ... Endocrine-related cancer 18 (1), 171, 2011 | 31 | 2011 |
| Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic … LI Hsu, AP Chokkalingam, FBS Briggs, K Walsh, V Crouse, C Fu, ... Cancer Causes & Control 26, 609-619, 2015 | 25 | 2015 |
| Comparative effectiveness of non-cisplatin first-line therapies for metastatic urothelial carcinoma: phase 2 IMvigor210 study versus US patients treated in the Veterans Health … N Vander Velde, A Guerin, R Ionescu-Ittu, S Shi, EQ Wu, SW Lin, LI Hsu, ... European Urology Oncology 2 (1), 12-20, 2019 | 24 | 2019 |
| Pathway analysis of genome-wide association study in childhood leukemia among Hispanics LI Hsu, F Briggs, X Shao, C Metayer, JL Wiemels, AP Chokkalingam, ... Cancer Epidemiology, Biomarkers & Prevention 25 (5), 815-822, 2016 | 20 | 2016 |
| PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia J Xiao, ST Lee, Y Xiao, X Ma, E Andres Houseman, LI Hsu, R Roy, ... International journal of cancer 135 (5), 1101-1109, 2014 | 20 | 2014 |
| Impact of anti-EGFR therapies on HER2-positive metastatic colorectal cancer: a systematic literature review and meta-analysis of clinical outcomes TS Bekaii-Saab, K Lach, LI Hsu, M Siadak, M Stecher, J Ward, ... The Oncologist 28 (10), 885-893, 2023 | 14 | 2023 |
| Matching on race and ethnicity in case-control studies as a means of control for population stratification AP Chokkalingam, MC Aldrich, K Bartley, LI Hsu, C Metayer, LF Barcellos, ... Epidemiology (Sunnyvale, Calif.) 1, 101, 2011 | 10 | 2011 |
| Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer H Singh, A Kang, L Bloudek, LI Hsu, M Corinna Palanca-Wessels, ... JNCI Cancer Spectrum 8 (1), pkad082, 2024 | 7 | 2024 |
| Economic burden of relapsed/refractory chronic lymphocytic leukemia. A Guerin, S Ray, G Gauthier, LI Hsu, M Zhdanava, J Héroux, EQ Wu Journal of Clinical Oncology 33 (15_suppl), e18065-e18065, 2015 | 6 | 2015 |
| Real-world patient characteristics and treatment patterns associated with tucatinib therapy in patients with HER2+ metastatic breast cancer. CK Anders, E Neuberger, NRM Schwartz, K Bartley, LI Hsu, G Wong, ... Journal of Clinical Oncology 41 (16_suppl), 1051-1051, 2023 | 4 | 2023 |
| Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer PA Kaufman, E Neuberger, NRM Schwartz, S Wang, Y Liu, LI Hsu, ... Frontiers in Oncology 13, 1264861, 2023 | 3 | 2023 |
| impact of low-grade adverse events (AEs) on health-related quality of life (HRQoL) in adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous … L Chen, A Guerin, M Marynchenko, R Ionescu-Ittu, R Hiscock, R Nitulescu, ... Blood 122 (21), 4038, 2013 | 3 | 2013 |
| Real-world treatment patterns in patients with HER2-amplified metastatic colorectal cancer: a clinical-genomic database study JH Strickler, LI Hsu, P Wright, M Stecher, MF Siadak, ... Journal of the National Comprehensive Cancer Network 21 (8), 805-812. e1, 2023 | 2 | 2023 |
| 439P Characteristics and treatment patterns among patients with HER2-amplified advanced/metastatic colorectal cancer (mCRC): A clinical-genomic database study JH Strickler, LI Hsu, K DeBusk, P Wright, M Stecher, M Siadak, ... Annals of Oncology 32, S554, 2021 | 2 | 2021 |
| Practice patterns in metastatic castration-resistant prostate cancer (mCRPC): Evidence from the veterans health administration A Halwani, Z Burningham, KM Rasmussen, V Patil, S Narayanan, SW Lin, ... Annals of Oncology 28, v277-v278, 2017 | 2 | 2017 |
